Gapping up
In reaction to earnings/guidance:
- HOME +46.9% (guides JulQ revs well ahead of consensus), MOBL +18.7%, SANM +16.1%, APA +15.4% (also announes major oil discovery), DBD +12.4%, QCOM +12% (also announces settlement agreement with Huawei), CARS +11.2%, UPS +10.8%, MD +9.9%, SKY +9.8%, MGRC +9.7%, CMPR +9.7%, UCTT +9.6% (also announces expansion into Malaysia), HOLX +9.4%, HBI +9.3%, TPX +8.6%, CROX +8.4%, RIG +7.8%, MTSI +7.5%, CTSH +7% (also names new CFO), BLKB +6.8%, QRVO +6.6%, LKQ +5.7%, EVLO +5.7%, DWSN +5.6%, ACGL +5.3%, AX +5.1%, PBI +5.1%, MAS +4.7%, SAH +4.6%, SCI +4.5%, MKSI +4.5%, EGOV +4.4%, GPI +4.4%, BUD +4.3%, CNMD +4%, MIXT +3.9%, GNRC +3.8%, COOP +3.8%, ORBC +3.8%, ORLY +3.6%, NWHM +3.6%, CHDN +3.5%, ONEW +3.4%, RGEN +3.4%, PYPL +3.2%, FTI +3.2%, CMCSA +3.1%, NVCR +3%, BC +2.9%, NNA +2.9%, KNSA +2.5%, LNTH +2.5%, SIRI +2.4%, NLY +2.3%, IP +2.3%, AZN +2.2%, MEOH +2.1%, MANT +2.1%, TXT +2.1%, KHC +2.1%, PG +2%, PS +1.9%, SWK +1.9%, AGCO +1.7%, TW +1.6%, SFM +1.5%, AVTR +1.5%, MC +1.3%, COR +1.3%, ALXN +1.3%, MCO +1.3%, QURE +1.3%, FBHS +1.2%, WERN +1.1%, TFX +1.1%, ODFL +1.1%, SRI +1%, LTRN +1%, RFP +1%
Other news:
- BLNK +27.9% (extends momentum following +33% move during Wed trading session)
- APA +14.8% (APA and TOT announce major oil discovery at Kwaskwasi-1 offshore Suriname)
- PRK +11.4% (to join S&P SmallCap 600)
- LIVX +7.3% (announces linear OTT distribution agreement with XUMO)
- CALX +4.4% (prices upsized public offering of 2.8 mln common shares, increased from 1.7 mln shares, at $20.00/share)
- DGX +3% (receives FDA authorization for new diagnostics lab model to increase COVID-19 molecular diagnostics capacity)
- SGMO +3% (to collaborate with Novartis (NVS) to develop genomic medicines for autism and other neurodevelopmental disorders)
- JNJ +2.3% (reports single dose of its COVID-19 vaccine candidate demonstrates robust protection in pre-clinical studies)
- PDFS +2% (partners with Advantest to build Cloud Powered by Exensio; Advantest becomes a significant stockholder in PDF Solutions in private placement)
- LILA +1.7% (acquires Telefonica's (TEF) operations in Costa Rica)
- RSG +1.3% (increases dividend)
- TAK +1.2% (announces FDA granted Breakthrough Therapy Designation for its investigational drug pevonedistat for the treatment of patients with higher-risk myelodysplastic syndromes)
Analyst comments:
- APRN +2.9% (upgraded to Buy from Hold at Canaccord Genuity)
- AEO +0.8% (upgraded to Buy from Neutral at Citigroup)